The Supreme Court’s June 25, 2026, decision in Monsanto Company v. Durnell marks the most significant interpretation of FIFRA’s preemption provision since the earlier Bates v. Dow Agrosciences ruling.
The landmark ruling determined that state-law warnings requiring labeling “in addition to or different from” those approved by the U.S. Environmental Protection Agency are expressly preempted under federal law.
At the heart of the case is glyphosate, the active ingredient in Roundup, which EPA first registered in 1974 and has reviewed repeatedly over five decades.
Since 1991, each EPA review has concluded that glyphosate is not likely to be carcinogenic to humans when used according to label directions, and approved labeling has never included a cancer warning.
A conflicting 2015 determination by the International Agency for Research on Cancer classified glyphosate as “probably carcinogenic to humans,” creating one of the most prominent scientific disagreements in pesticide risk assessment.
That disagreement fueled thousands of state-law product liability suits, with plaintiffs alleging that prolonged Roundup exposure caused non-Hodgkin lymphoma and that Monsanto failed to warn consumers of the alleged cancer risk.
John Durnell brought one such action in Missouri state court after approximately twenty years of Roundup use, and a Missouri jury awarded him approximately $1.25 million in damages on his failure-to-warn claim.
The Supreme Court reversed, holding that Durnell’s state-law failure-to-warn claim would require a cancer warning on Roundup’s label, constituting a requirement “in addition to” and “different from” the label required by EPA under FIFRA.
Justice Ketanji Brown Jackson’s dissent, joined by Justice Neil Gorsuch, argued the majority interpreted FIFRA’s preemption provision too broadly by equating common-law damages actions with affirmative state labeling requirements.
Justice Jackson stated: “The EPA’s approval of a pesticide’s label does not create a labeling requirement under FIFRA. Instead, FIFRA’s key labeling requirement — the statutory prohibition on misbranding — continues to apply to registered pesticides even though the EPA has approved their labels.”
The decision has immediate implications for California’s Proposition 65 programme, which listed glyphosate as a substance known to cause cancer in 2017, and whose warning requirements now face additional grounds for invalidation under the Durnell ruling.
Beyond glyphosate, the ruling could similarly preempt Prop 65 warning requirements for other pesticides where EPA-approved labels do not include language about cancer, birth defects, or reproductive harm.
The decision does not eliminate pesticide litigation entirely, as theories including design defect, manufacturing defect, negligent testing, fraud, or warranty claims may still be asserted depending on the facts and applicable state law.
The ruling arrives alongside an Executive Order from the current Administration promoting domestic glyphosate production, reflecting a broader policy objective of strengthening domestic agricultural supply chains and crop protection access.
The emergence of the Make America Healthy Again movement adds a further political dimension, with many of its advocates questioning existing federal approaches to pesticide regulation and calling for greater scrutiny of glyphosate and other agricultural chemicals.
By limiting state-law failure-to-warn litigation, the Durnell decision may shift disputes over glyphosate toward EPA registration reviews, congressional oversight, and state regulatory programmes rather than courtrooms.
Ultimately, Durnell is about institutional authority rather than toxicology, confirming that Congress assigned EPA, not fifty different state tort systems, the responsibility of establishing nationally uniform pesticide labelling under FIFRA.